Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22*to detect bladder cancer - Comment

被引：0
|
作者：
Grossman, HB [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
来源：
JOURNAL OF UROLOGY | 1999年 / 162卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1956 / 1956
页数：1
相关论文
共 50 条
  • [21] Evaluation of the clinical value of urinary NMP22 as a marker in the screening and surveillance of transitional cell carcinoma of the urinary bladder - Editorial comment
    Witjes, F
    EUROPEAN UROLOGY, 2001, 40 (04) : 421 - 421
  • [22] Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer:: Comparison with urinary cytology and BTA test
    Del Nero, A
    Esposito, N
    Currò, A
    Biasoni, D
    Montanari, E
    Mangiarotti, B
    Trinchieri, A
    Zanetti, G
    Serrago, MP
    Pisani, E
    EUROPEAN UROLOGY, 1999, 35 (02) : 93 - 97
  • [23] Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder
    Heicappell, R
    Schostak, M
    Müller, M
    Miller, K
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2000, 60 (04): : 275 - 282
  • [24] CYFRA 21-1 quantity measurement in the urine of patients with carcinoma of the urinary bladder and tract
    Schambeck, CM
    Stieber, P
    Schmeller, N
    Hofmann, K
    Pahl, H
    FatehMoghadam, A
    ANTICANCER RESEARCH, 1997, 17 (4B) : 3063 - 3065
  • [25] Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer
    Stieber, P
    Schmeller, N
    Schambeck, C
    Hofmann, K
    Reiter, W
    Hasholzner, U
    FatehMoghadam, A
    ANTICANCER RESEARCH, 1996, 16 (6B) : 3793 - 3798
  • [26] COMPARISON OF CYTOKERATIN FRAGMENT 19 (CYFRA 21-1), TISSUE POLYPEPTIDE ANTIGEN (TPA) AND TISSUE POLYPEPTIDE SPECIFIC ANTIGEN (TPS) AS TUMOR-MARKERS IN LUNG-CANCER
    STIEBER, P
    DIENEMANN, H
    HASHOLZNER, U
    MULLER, C
    POLEY, S
    HOFMANN, K
    FATEHMOGHADAM, A
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1993, 31 (10): : 689 - 694
  • [27] Cytokeratin-19 fragment (CYFRA 21-1) in bladder cancer
    Morita, T
    Kikuchi, T
    Hashimoto, S
    Kobayashi, Y
    Tokue, A
    EUROPEAN UROLOGY, 1997, 32 (02) : 237 - 244
  • [28] Tissue polypeptide antigen in the follow-up of patients with urinary bladder cancer compared with conventional urine cytology
    Bantis, Athanasios
    Zissimopoulos, Athanasios
    Sountoulides, Petros
    Giannakopoulos, Stilianos
    Kalaitzis, Christos
    Athanassiadou, Pauline
    Agelonidou, Eleni
    Touloupidis, Stavros
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2010, 13 (03): : 213 - 217
  • [29] TISSUE POLYPEPTIDE ANTIGEN IN NORMAL AND NEOPLASTIC URINARY-BLADDER - PRELIMINARY REPORTS
    SENATORE, S
    ATTOLINI, A
    LUCCARELLI, S
    CANDITA, F
    TRABUCCO, M
    ONCOLOGY, 1987, 44 (02) : 118 - 123
  • [30] Diagnostic value of urinary bladder cancer (UBC) antigen for urinary bladder transitional cell carcinoma (TCC)
    Marshutina, N.
    Sergeeva, N.
    Rodina, I
    Rusakov, I
    Sergeeva, V
    TUMOR BIOLOGY, 2006, 27 : 52 - 52
12345